Manav Drugs

Mumbai, India Founded: 1997 • Age: 29 yrs
Manufactures active pharmaceutical ingredients, intermediates, formulations, and medical disposables.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Manav Drugs

Manav Drugs is a company based in Mumbai (India) founded in 1997. It operates as a B2B. Manav Drugs operates in a competitive market with competitors including Natco Pharma, Alembic Pharmaceuticals, Almac Group, Indoco Remedies and Concord Biotech, among others.

  • Headquarter Mumbai, India
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Manav Drugs Private Limited
  • Date of Incorporation 15 May, 1998
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    -$459.61 (USD)
    5.83
    as on Mar 31, 2021
  • EBITDA
    -$386.51 (USD)
    34.02
    as on Mar 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Manav Drugs

Premium access

Detailed funding history for Manav Drugs

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Manav Drugs

Investments
Premium access

Investment portfolio details for Manav Drugs

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Manav Drugs

Premium access

Detailed financials for Manav Drugs

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Manav Drugs Comparisons

Manav Drugs Primary company
Description
Manufactures active pharmaceutical ingredients, intermediate...
Location
Mumbai, India
Founded Year
1997
Annual Revenue
Not available
Net Profit
-$459.61 (USD)
EBITDA
-$386.51 (USD)
Employees
Not available
Premium access

Peer comparison for Manav Drugs

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Manav Drugs

Manav Drugs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natco Pharma, Alembic Pharmaceuticals, Almac Group, Indoco Remedies and Concord Biotech, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
APIs and finished dosage forms are developed and manufactured.
Locked Locked Locked
Manufacturer & supplier of generic pharmaceuticals
Locked Locked Locked
Integrated CDMO services for biopharma R&D and manufacturing are offered.
Locked Locked Locked
APIs manufacturing and formulation services are provided in therapeutic segments.
Locked Locked Locked
APIs and enzymes are manufactured through fermentation by the CDMO.
Locked Locked Locked
APIs and finished products are developed and manufactured.
Premium access

Detailed competitors of Manav Drugs

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Manav Drugs

Premium access

Complete news archive for Manav Drugs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manav Drugs

Manav Drugs was founded in 1997.

Manav Drugs is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Manav Drugs, founded in 1997 in Mumbai, India, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api and formulations. Manufactures active pharmaceutical ingredients, intermediates, formulations, and medical disposables. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Manav Drugs's top competitors include Natco Pharma, Concord Biotech and Alembic Pharmaceuticals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available